Press release -

Prospects of Multiple Sclerosis Drug Market Globally

Global Multiple Sclerosis Drug Market 2010-2025

The multiple sclerosis (MS) treatments market is one of the largest for CNS disorders, with total pharmaceutical revenues of over $8bn in 2009. Revenues for MS treatments will rise significantly from 2010 to 2025, our new study reveals. Rising disease prevalence, expanding patient populations, technological advances and widening healthcare provision for MS will drive the market upwards. In Global Multiple Sclerosis Drug Market 2010-2025 we analyse and explain trends in this market, providing sales forecasts and other core analyses that you require. Our report explains why the market will expand, revealing where the most-exciting developments will lie. ( )

Which multiple sclerosis products will lead the market from 2010 onwards? Where will the best commercial opportunities lie in future years? What are the most-promising R&D pipeline developments? What are the most-crucial drivers and restraints for the treatment of MS? This report will help you to understand current trends and future opportunities in this industry and market. In particular, our new report covers leading products in depth, focussing on both commercial and therapeutic prospects from 2010 to 2025:

* Copaxone
* Avonex
* Rebif
* Betaferon
* Tysabri.

Comprehensive analysis of the global multiple sclerosis drug market

Global Multiple Sclerosis Drug Market 2010-2025 critically examines that sector through a comprehensive review of information sources. We harness both primary and secondary research. This report provides unique sales forecasts, market share analyses, discussions of pipeline developments and analyses of commercial drivers and restraints, including a SWOT analysis. There are over 45 tables and figures included, as well as three original interviews with relevant experts. The result is a comprehensive market- and industry-centred study, with detailed analyses to benefit your work.

Our report will provide you with the following benefits in particular:

* You will assess the current market for multiple sclerosis drugs, with informed discussions
* You will analyse the future MS drugs market, including a global sales forecast from 2010 to 2025, with informed discussions
* You will receive sales forecasts for the leading MS drugs from 2010 to 2025, with detailed supporting information
* You will receive sales forecasts for leading national markets from 2010 to 2025 (US, Japan, Germany, France, UK, Italy, Spain, India and China), with geographical market characteristics discussed
* You will examine the leading companies in this market and their future outlook
* You will examine commercial drivers and restraints in depth
* You will discover the most-exciting R&D developments in this sector
* You will read expert opinions from our original survey, with full interview transcripts provided.

To know more and to buy a copy of your report feel free to visit :


Contact us at :

Bharat Book Bureau
Tel: +91 22 27578668
Fax: +91 22 27579131
Follow us on twitter:


  • Diseases


  • multiple sclerosis
  • drugs
  • market research reports
  • aggrigator
  • demand forecast
  • market
  • research
  • report
  • market forecast
  • market share
  • market growth
  • market leaders
  • market report
  • market research


Bharat Book Bureau facilitates companies to take the lead of their industry with best practice business strategies and intelligence, through a unique combination of published reports, databases, country reports, company profiles and customized research services. Bharat Book Bureau provides strategic information tools to the executives, business analysts, and knowledge managers that will help them to probe into and support critical, timely business decisions and strategies.